Search results
Results from the WOW.Com Content Network
Alpha radiation is a nuclear phenomenon in which a heavy radionuclide emits an energetic alpha particle (consisting of two protons and two neutrons) and transmutes to a different radionuclide. The emitted alpha particle has a range in tissue of only 40-90 microns, which minimizes collateral damage when used for treatment purposes.
Targeted alpha-particle therapy (or TAT) is an in-development method of targeted radionuclide therapy of various cancers. It employs radioactive substances which undergo alpha decay to treat diseased tissue at close proximity. [1] It has the potential to provide highly targeted treatment, especially to microscopic tumour cells.
Alpha radiation has a very short range in tissues compared to beta or gamma radiation: around 2–10 cells. This reduces damage to surrounding healthy tissues, producing an even more localized effect than the beta-emitter strontium-89, also used to treat bone cancer. [17] Taking account of its preferential uptake by bone and the alpha particles ...
Proton beam therapy has been shown to be just as effective as traditional chemotherapy, with fewer side effects and less treatment time. High-dose proton radiation could shorten breast cancer ...
This therapy is called "Diffusing Alpha-emitting Radiation Therapy" or DaRT. [15] [16] Nanotechnology in thermal ablation and immunotherapy Currently nanotechnologies has been continuously developed for cancer immunotherapy for their versatility in integration of therapeutic and diagnostic (or termed 'theranostic') multimodalities.
Lymphedema, a condition of localized fluid retention and tissue swelling, can result from damage to the lymphatic system sustained during radiation therapy. It is the most commonly reported complication in breast radiation therapy patients who receive adjuvant axillary radiotherapy following surgery to clear the axillary lymph nodes . [26] Cancer
Staging breast cancer is the initial step to help physicians determine the most appropriate course of treatment. As of 2016, guidelines incorporated biologic factors, such as tumor grade, cellular proliferation rate, estrogen and progesterone receptor expression, human epidermal growth factor 2 (HER2) expression, and gene expression profiling into the staging system.
Radium-224 is a radioactive atom that is utilized as a source of alpha radiation in a cancer treatment device called DaRT (diffusing alpha emitters radiation therapy). Each radium-224 atom undergoes a decay process producing 6 daughter atoms. During this process, 4 alpha particles are emitted.